Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
HAI Solutions is a private medical device company developing products for intravenous care and vascular access, with a focus on reducing contamination risks in hospital settings. The company’s lead commercial product is the QIKCAP System, an FDA De Novo granted UV-C microbial reduction device for luer-activated needleless IV connectors. HAI Solutions also markets the Multiport Delivery Device, a patented inline IV delivery device designed to improve medication administration workflow, compliance, and safety. Its products are aimed at high-acuity care environments such as operating rooms, intensive care units, and emergency departments. The company positions itself as a healthcare innovation platform focused on infection prevention, IV therapy workflow improvement, and patient safety.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on HAI Solutions.